Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histone eviction. Despite its wide therapeutic efficacy...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Jihoon Lee, Min-Koo Choi, Im-Sook Song
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: MDPI AG 2023-05-01
Cyfres:Pharmaceuticals
Pynciau:
Mynediad Ar-lein:https://www.mdpi.com/1424-8247/16/6/802

Eitemau Tebyg